Table 1 The association between AURKAIP1 expression and clinicopathological factors in TNBC patients (n = 100).

From: AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer

Parameters

AURKAIP1 expression

p value

High (n = 50)

Low (n = 50)

Age

≤50

27

35

ns

>50

23

15

Menopause

Yes

22

15

ns

No

28

35

Grade

I + II

23

26

ns

III

27

24

T

T1-T2

39

49

**

T3-T4

11

1

N

Negative

15

39

****

Positive

35

11

Stage

I + II

26

42

****

III + IV

24

8

  1. Chi-square test was used for comparing high and low groups of AURKAIP1 expression, *p < 0.05 was considered significant; ns, not significant; **p < 0.01; ****p < 0.0001.
Back to article page